• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Foresight Acquisition Corp.

    12/1/21 4:32:58 PM ET
    $FORE
    Finance
    Get the next $FORE alert in real time by email
    DEFA14A 1 d217719ddefa14a.htm DEFA14A DEFA14A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

     

     

    Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

    Check the appropriate box:

     

    ☐   Preliminary Proxy Statement
    ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☐   Definitive Proxy Statement
    ☒   Definitive Additional Materials
    ☐   Soliciting Material under §240.14a-12

    Foresight Acquisition Corp.

    (Name of Registrant as Specified In Its Charter)

    N/A

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

    ☒   No fee required.
    ☐   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
      (1)  

    Title of each class of securities to which transaction applies:

     

      (2)  

    Aggregate number of securities to which transaction applies:

     

      (3)  

    Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

     

      (4)  

    Proposed maximum aggregate value of transaction:

     

      (5)  

    Total fee paid:

     

    ☐   Fee paid previously with preliminary materials.
    ☐   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
      (1)  

    Amount Previously Paid:

     

         

      (2)  

    Form, Schedule or Registration Statement No.:

     

         

      (3)  

    Filing Party:

     

         

      (4)  

    Date Filed:

     

         

     

     

     


     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): November 24, 2021

     

     

    Foresight Acquisition Corp.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-40043   85-2992794
    (State or other jurisdiction
    of incorporation)
      (Commission
    File Number)
      (I.R.S. Employer
    Identification No.)

     

    2045 W. Grand Avenue, Ste. B, PMB 82152

    Chicago, IL

      60612
    (Address of principal executive offices)   (Zip Code)

    (312) 882-8897

    (Registrant’s telephone number, including area code)

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Units, each consisting of one share of Class A Common Stock and one-third of one Warrant   FOREU   The Nasdaq Stock Market LLC
    Class A Common Stock, par value $0.0001 per share   FORE   The Nasdaq Stock Market LLC
    Warrants, each warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50   FOREW   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 5.07.

    Submission of Matters to a Vote of Security Holders.

    On November 24, 2021, Foresight Acquisition Corp., a Delaware corporation (“Foresight”), re-convened its special meeting of Foresight stockholders (the “Special Meeting”) in connection with the transactions contemplated by the Agreement and Plan of Merger and the Transaction and Combination Agreement as described in the proxy statement filed by Foresight with the Securities and Exchange Commission on October 28, 2021 and mailed to Foresight’s stockholders. Present at the reconvened Special Meeting were holders of 28,496,046 shares of Class A common stock (“Class A Common Stock”) of Foresight in person or by proxy, representing 70.6% of the voting power of the Class A Common Stock as of October 8, 2021, the record date for the Special Meeting (the “Record Date”), and constituting a quorum for the transaction of business. As of the Record Date, there were 40,363,750 shares of Class A Common Stock issued and outstanding.

    The sole proposal that was presented at the reconvened Special Meeting was the “Stockholder Adjournment Proposal”—To consider and vote upon a proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies if there are insufficient votes for, or otherwise in connection with, the approval of any of the stockholder proposals. The stockholders approved the Stockholder Adjournment Proposal. The voting results were as follows:

     

    Votes For   Votes Against   Abstentions
    26,150,988   2,290,958   54,100

    The Special Meeting was adjourned to 7:00 a.m., Central Time, on Friday, December 3, 2021.

     

    2


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    FORESIGHT ACQUISITION CORP.

    By:  

    /s/ Michael Balkin

    Name: Michael Balkin

    Title: Chief Executive Officer

    Date: December 1, 2021

    Get the next $FORE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FORE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FORE
    SEC Filings

    See more
    • Foresight Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant’s Certifying Accountant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Change in Shell Company Status, Regulation FD Disclo

      8-K - P3 Health Partners Inc. (0001832511) (Filer)

      12/9/21 5:17:10 PM ET
      $FORE
      Finance
    • Foresight Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Foresight Acquisition Corp. (0001832511) (Filer)

      12/3/21 4:48:34 PM ET
      $FORE
      Finance
    • SEC Form 25-NSE filed by Foresight Acquisition Corp.

      25-NSE - Foresight Acquisition Corp. (0001832511) (Subject)

      12/3/21 4:31:22 PM ET
      $FORE
      Finance

    $FORE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • P3 Health Partners Closes Business Combination with Foresight Acquisition Corp. and Will Begin Trading on the Nasdaq

      NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners ("P3" or "Company"), a patient-centered and physician-led population health management company, announced today that it has closed its previously announced business combination with Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight"). The transaction was approved at a special meeting of Foresight's stockholders on December 3, 2021. The combined company will be named P3 Health Partners Inc. and will be led by P3's management team. Its shares of Class A common stock and warrants are expected to begin trading December 6, 2021, on the Nasdaq under the ticker symbols "PIII" and "PIIIW", respectively. "At P3, we utilize our pro

      12/3/21 5:24:12 PM ET
      $FORE
      Finance
    • Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination

      NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") that was initially convened at 9:00 a.m. Central Time on November 18, 2021 and adjourned to today, was reconvened today at 7:00 a.m. Central Time and further adjourned until 7:00 a.m. Central Time on December 3, 2021. As anticipated, the Special Meeting was further adjourned to provide Foresight and P3 additional time to file a proxy supplement to the definitive proxy statement that was filed with the

      11/24/21 10:39:40 AM ET
      $FORE
      Finance
    • Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination

      NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") was convened today at 9:00 a.m. Central Time and adjourned until 7:00 a.m. Central Time on November 24, 2021. The Special Meeting was adjourned to give Foresight's stockholders additional time to consider additional disclosure to be included in a supplement to the Proxy Statement that was filed with the Securities and Exchange Commission ("SEC") on October 28, 2021 (the "Proxy Statement") and mailed to

      11/18/21 11:02:22 AM ET
      $FORE
      Finance

    $FORE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3: New insider Hudson Vegas Investment Spv, Llc claimed ownership of 43,974,331 units of Class V Common Stock

      3 - P3 Health Partners Inc. (0001832511) (Issuer)

      12/17/21 6:00:35 PM ET
      $FORE
      Finance
    • SEC Form 3: New insider Chicago Pacific Founders Ugp, Llc claimed ownership of 8,732,517 shares and claimed ownership of 91,269,317 units of Class V Common Stock (Amendment)

      3/A - P3 Health Partners Inc. (0001832511) (Issuer)

      12/13/21 4:50:43 PM ET
      $FORE
      Finance
    • SEC Form 3: New insider Chicago Pacific Founders Ugp, Llc claimed ownership of 91,269,317 units of Class V Common Stock and claimed ownership of 8,872,593 shares

      3 - P3 Health Partners Inc. (0001832511) (Issuer)

      12/7/21 9:21:55 PM ET
      $FORE
      Finance

    $FORE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Foresight Acquisition Corp.

      SC 13D - P3 Health Partners Inc. (0001832511) (Subject)

      12/17/21 4:08:59 PM ET
      $FORE
      Finance
    • SEC Form SC 13D filed by Foresight Acquisition Corp.

      SC 13D - P3 Health Partners Inc. (0001832511) (Subject)

      12/13/21 5:24:05 PM ET
      $FORE
      Finance
    • SEC Form SC 13D filed by Foresight Acquisition Corp.

      SC 13D - P3 Health Partners Inc. (0001832511) (Subject)

      12/13/21 4:17:19 PM ET
      $FORE
      Finance